BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND MECOM, MDS1-EVI1, EVI1, 2122, ENSG00000085276, Q03112, PRDM3
34 results:

  • 1. Non-Canonical Cannabinoid Receptors with Distinct Binding and Signaling Properties in prostate and Other cancer Cell Types Mediate Cell Death.
    Shoeib AM; Benson LN; Mu S; MacMillan-Crow LA; Prather PL
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328467
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Prostatic metaplasia and pilar differentiation in gender-affirming mastectomy specimens.
    Kim CF; Jou D; Ganor O; Boskey ER; Kozakewich H; Vargas SO
    Mod Pathol; 2022 Mar; 35(3):386-395. PubMed ID: 34689157
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [On the practice of therapy decision in locally limited prostate cancer: surgery vs. radiation-who benefits? : Allocation and results of a monocentric, cumulative long-term study].
    Böhm W-U; Koch R; Latarius S; Mehnert A; Werner C; Wirth MP
    Urologe A; 2022 Mar; 61(3):282-291. PubMed ID: 34338813
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Pubectomy and urinary reconstruction provides definitive treatment of urosymphyseal fistula following prostate cancer treatment.
    Andrews JR; Hebert KJ; Boswell TC; Avant RA; Boonipatt T; Kreutz-Rodrigues L; Bakri K; Houdek MT; Karnes RJ; Viers BR
    BJU Int; 2021 Oct; 128(4):460-467. PubMed ID: 33403768
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. 99mTc-PSMA SPECT/CT Versus 68Ga-PSMA PET/CT in the Evaluation of Metastatic prostate cancer.
    Fallahi B; Khademi N; Karamzade-Ziarati N; Fard-Esfahani A; Emami-Ardekani A; Farzanefar S; Eftekhari M; Beiki D
    Clin Nucl Med; 2021 Feb; 46(2):e68-e74. PubMed ID: 33234922
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Cannabinoids and prostate cancer: A Systematic Review of Animal Studies.
    Singh K; Jamshidi N; Zomer R; Piva TJ; Mantri N
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872551
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Measures of body fatness and height in early and mid-to-late adulthood and prostate cancer: risk and mortality in The Pooling Project of Prospective Studies of Diet and cancer.
    Genkinger JM; Wu K; Wang M; Albanes D; Black A; van den Brandt PA; Burke KA; Cook MB; Gapstur SM; Giles GG; Giovannucci E; Goodman GG; Goodman PJ; Håkansson N; Key TJ; Männistö S; Le Marchand L; Liao LM; MacInnis RJ; Neuhouser ML; Platz EA; Sawada N; Schenk JM; Stevens VL; Travis RC; Tsugane S; Visvanathan K; Wilkens LR; Wolk A; Smith-Warner SA
    Ann Oncol; 2020 Jan; 31(1):103-114. PubMed ID: 31912782
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Cannabinoid WIN 55,212-2 induces cell cycle arrest and apoptosis, and inhibits proliferation, migration, invasion, and tumor growth in prostate cancer in a cannabinoid-receptor 2 dependent manner.
    Roberto D; Klotz LH; Venkateswaran V
    Prostate; 2019 Feb; 79(2):151-159. PubMed ID: 30242861
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Treatment of stress urinary incontinence after prostatectomy with the adjustable transobturator male system (ATOMS®) with preattached scrotal port.
    Esquinas C; Arance I; Pamplona J; Moraga A; Dorado JF; Angulo JC
    Actas Urol Esp (Engl Ed); 2018 Sep; 42(7):473-482. PubMed ID: 29642999
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Transperineal ultrasound imaging of the internal pudendal artery in arteriogenic erectile dysfunction].
    Povelitsa E; Dosta NI; Parhomenko OV; Nitkin DM; Shesternja AM; Anichkin VV
    Urologiia; 2017 Sep; (4):55-61. PubMed ID: 28952694
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Prominent Oncogenic Roles of evi1 in Breast Carcinoma.
    Wang H; Schaefer T; Konantz M; Braun M; Varga Z; Paczulla AM; Reich S; Jacob F; Perner S; Moch H; Fehm TN; Kanz L; Schulze-Osthoff K; Lengerke C
    Cancer Res; 2017 Apr; 77(8):2148-2160. PubMed ID: 28209621
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Ecotropic viral integration site 1, a novel oncogene in prostate cancer.
    Queisser A; Hagedorn S; Wang H; Schaefer T; Konantz M; Alavi S; Deng M; Vogel W; von Mässenhausen A; Kristiansen G; Duensing S; Kirfel J; Lengerke C; Perner S
    Oncogene; 2017 Mar; 36(11):1573-1584. PubMed ID: 27617580
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The cannabinoid WIN 55,212-2 prevents neuroendocrine differentiation of LNCaP prostate cancer cells.
    Morell C; Bort A; Vara D; Ramos-Torres A; Rodríguez-Henche N; Díaz-Laviada I
    Prostate Cancer Prostatic Dis; 2016 Sep; 19(3):248-57. PubMed ID: 27324222
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Survival outcomes of combined external beam radiotherapy and brachytherapy vs. brachytherapy alone for intermediate-risk prostate cancer patients using the National cancer Data Base.
    Amini A; Jones BL; Jackson MW; Rusthoven CG; Maroni P; Kavanagh BD; Raben D
    Brachytherapy; 2016; 15(2):136-46. PubMed ID: 26825856
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Health resource use after robot-assisted surgery vs open and conventional laparoscopic techniques in oncology: analysis of English secondary care data for radical prostatectomy and partial nephrectomy.
    Hughes D; Camp C; O'Hara J; Adshead J
    BJU Int; 2016 Jun; 117(6):940-7. PubMed ID: 26696305
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Survival Outcomes of Whole-Pelvic Versus prostate-Only Radiation Therapy for High-Risk prostate cancer Patients With Use of the National cancer Data Base.
    Amini A; Jones BL; Yeh N; Rusthoven CG; Armstrong H; Kavanagh BD
    Int J Radiat Oncol Biol Phys; 2015 Dec; 93(5):1052-63. PubMed ID: 26581142
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Body size across the life course and prostate cancer in the Health Professionals Follow-up Study.
    Möller E; Wilson KM; Batista JL; Mucci LA; Bälter K; Giovannucci E
    Int J Cancer; 2016 Feb; 138(4):853-65. PubMed ID: 26355806
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The Use of Styrene Maleic Acid Nanomicelles Encapsulating the Synthetic Cannabinoid Analog WIN55,212-2 for the Treatment of cancer.
    Xian S; Parayath NN; Nehoff H; Giles NM; Greish K
    Anticancer Res; 2015 Sep; 35(9):4707-12. PubMed ID: 26254360
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. evi1-rearranged acute myeloid leukemias are characterized by distinct molecular alterations.
    Lavallée VP; Gendron P; Lemieux S; D'Angelo G; Hébert J; Sauvageau G
    Blood; 2015 Jan; 125(1):140-3. PubMed ID: 25331116
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Transcription factors involved in prostate gland adaptation to androgen deprivation.
    Rosa-Ribeiro R; Nishan U; Vidal RO; Barbosa GO; Reis LO; Cesar CL; Carvalho HF
    PLoS One; 2014; 9(6):e97080. PubMed ID: 24886974
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.